Business, Media & Communications, Science

NICE accelerates time-to-value for businesses globally with new RoboticProcess Automation offer

New commitment-free ‘try and buy’ model allows businesses to swiftly adopt or expand unattended automation and simplify the purchasing decision process HOBOKEN, N.J.–(BUSINESS WIRE)–Organizations globally have been impacted by dynamic changes in recent months and are in critical need of efficiencies in

Business

LianBio announces clearance to initiate the Phase 3 PROOF trial of Infigratinib in patients with locally advanced or metastatic unresectable cholangiocarcinoma with FGFR2 gene fusions in China

SHANGHAI & PRINCETON, N.J.–(BUSINESS WIRE)–LianBio, a biotechnology company focused on bringing paradigm-shifting medicines to patients in China and major Asian markets, today announced that it has received clearance from the Center for Drug Evaluation (CDE) of the China National Medical Products Administration